Mitchell Li

Associate, New York

Biography

Overview

Mitchell is an associate in the Firm's Tax practice. Mitchell advises clients on a broad range of corporate, partnership, and international tax matters, including structuring, and providing tax advice on, complex domestic and cross-border business transactions, tax-free reorganizations, and securities offerings.

Mitchell also assists clients with international tax planning and provides advice on various international tax issues, including controlled foreign corporations, FIRPTA, foreign currency exchange, and investments by foreign investors in the United States.

Bars and Courts
New York State Bar
Education
JD
Northwestern University Pritzker School of Law
LLM
Cornell Law School
LLB
Peking University
Languages
English
Mandarin

Experience

Recent transactions include representation of:

dMY Technology Group, Inc. (NYSE: DMYT), a SPAC, in its US$1.78 billion business combination with Rush Street Interactive, LP, a US-based online casino and sports betting company.

dMY Technology Group, Inc. II (NYSE: DMYD), a SPAC, in its US$1.68 billion business combination with UK-based Genius Sports Group.

Forum Merger III Corporation (NASDAQ: FIII), a special-purpose acquisition company (SPAC), in its US$1.4 billion business combination with Electric Last Mile, Inc., an electric vehicle company.

Netfin Acquisition Corp., a special-purpose acquisition company, in its business combination with Triterras Fintech Pte. Ltd, a Singapore company, for aggregate consideration of approximately US$585 million in a mixture of cash and stock.

Shine Holdco (UK) Ltd., owner of the International Car Wash Group, on its sale to Driven Brands, the parent company of some of North America’s leading automotive service brands. 

FS Development Corp. (NASDAQ: FSDC), a SPAC, in its US$216 million business combination with Gemini Therapeutics, Inc., a clinical stage precision medicine company developing treatments for genetically defined age-related macular degeneration.

UBS Securities LLC and BTIG, LLC as joint-book running managers on Bridgetown Holdings Ltd.’s US$550 million initial public offering of 55,000,000 units at a price of US$10.00 per unit on the Nasdaq Capital Market. Bridgetown, a Cayman Islands exempted company, is a blank check company whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

Avon Rubber p.l.c. (LSE: AVON), a leading provider of life critical personal protection systems to military and first responder markets, in its US$130 million acquisition of Team Wendy, LLC, a leading supplier of critical protective systems including helmets and helmet liner and retention systems for military and first responders.

OpenText Corp. (NASDAQ: OTEX, TSE: OTEX), a Canadian seller and developer of enterprise information management software and one of Canada's largest software companies, in its US$75 million acquisition of XMedius, a provider of secure information exchange and unified communication solutions with locations in the United States, Canada and Europe.

Advance Stores Company, Inc., a wholly owned subsidiary of Advance Auto Parts, Inc. (a leading automotive aftermarket parts provider), in its acquisition of the DieHard brand from Transform Holdco LLC, a leading integrated retailer.

Baxter International Inc. (NYSE: BAX), a Fortune 500 American health care company, in its acquisition of the Seprafilm adhesion barrier device and related assets from Sanofi S.A. (NASDAQ: SNY).

GreensLedge Capital Markets LLC as placement agent on the issuance of US$283.5 million of collateralized debt obligation notes.

Antin Infrastructure Partners in the US$1.25 billion acquisition of Veolia Group's district energy assets in the United States, which is comprised of steam, hot and chilled water and electricity production plants, including cogeneration plants, and 13 networks in 10 US cities.

Lantheus Holdings, Inc. (NASDAQ: LNTH), a leader in the development, manufacture and commercialization of innovative diagnostic imaging agents and products, in the US$500 million acquisition of Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX).